GNH USA

Europe — EMA

Orobupre (Buprenorphine)

Buprenorphine, the active ingredient in Orobupre, is a partial opioid presented as a tablet for sublingual use. It is used in the management of moderate to severe pain and opioid dependence in adults.

International sale not permitted. Listed for the domestic market and B2B only.

Request sourcing

1
Pack/s

What is Buprenorphine?

Buprenorphine, the active ingredient in Orobupre, is a partial opioid presented as a tablet for sublingual use. It is used in the management of moderate to severe pain and opioid dependence in adults. GNH USA supplies Orobupre as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Orobupre as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Buprenorphine used for?

Buprenorphine acts through the opioid system and is prescribed for several clinical indications.

- Opioid dependence: Helps helps to manage withdraw withdraw the        ... -  ... ... ...  ...  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... -  ....  ....  -  ...

What are the side effects of Buprenorphine?

This    … .... .... .... .... ...

What precautions apply to Buprenorphine?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Buprenorphine
Route
Oromucosal Use
Manufacturer
Ethypharm
Origin
EU

Related products